已收盘 11-20 16:00:00 美东时间
-0.570
-1.43%
Hemab reports new HMB-002 Von Willebrand disease data, and introduced HMB-003, targeting heavy menstrual bleeding.
07-14 01:47
Companies Reporting Before The Bell • Cato (NYSE:CATO) is projected to report e...
05-21 19:11